Valtech - Experts Speak

Experts Speak

Who knows more about treating MR than the professionals who devote their careers to it?

At Valtech, we work hand-in-hand with some of the world’s leading heart specialists. Needless to say, when people with their knowledge and experience have something to say, we listen very closely.

Experts Speak - Karl-Heinz Kuck, M.D.

Karl-Heinz Kuck, M.D.

Head of Cardiology department
ASKLEPIOS Klinik St. Georg, Hamburg

"The overall experience with Cardioband therapy is extremely satisfying. We were able to apply the technology to all the patients in the clinical study without a single failure. I really believe that this is the very first technology that can be applied systematically around the world to patients suffering from secondary mitral regurgitation.
For me the Cardioband is the only technology that can reproducibly reduce the septo-lateral diameter.
Cardioband is a major step forward in the history of mitral valve disease and treatment."

Experts Speak - Michael Mack, M.D.

Michael Mack, M.D.

Medical Director, Cardiovascular Surgery
Baylor Health Care System

"This is an interesting time for the FMR space.
The evolution and success of Cardioband has worked to move this field forward and is based on common surgical practice of performing an annuloplasty in patients with FMR. Early results of research has indicated that transcatheter surgical annuloplasty using Cardioband Annuloplasty System may be a viable treatment option.
This is a novel technology which may ultimately allow patient selection at earlier stages of heart failure for treatment."

Experts Speak - Francesco Maisano, M.D.

Francesco Maisano, M.D.

Klinik für Herz- und Gefässchirurgie
UniversitätsSpital Zürich

"The future of FMR treatment lies in the repair-and-replace paradigm. MR repair with Cardioband can be the first-line therapy for severe MR patients. Additionally, early-stage repair can support ventricular reverse remodeling while keeping the options open for the patient, supporting the technology's use at earlier stages."

Experts Speak - Georg Nickenig, M.D.

Georg Nickenig, M.D.

Med. Klinik und Poliklinik II
Universitätsklinikum Bonn

"We have extremely convincing results with the treatment of more than a dozen patients thus far. Cardioband has proven its efficacy by significantly reducing MR in each patient. In addition, its safety profile is also proven and this is true for centers across the board.
Cardioband is a very exciting, innovative and novel technique."